# Guangyu Biomedical Technology (Suzhou) Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/guangyu-biomedical-technology-suzhou-co

- Industry: Biotechnology
- Headquarters: Suzhou, China
- Latest round: Angel (Aug 18, 2022)
- Investors on record: 1

## About

Based in Suzhou, China, and founded in 2022, Guangyu Biomedical Technology (Suzhou) Co., Ltd. is a biotech company that focuses on developing an in-vivo flow cytometer (IVFC). In August 2022, Guangyu Biomedical Technology (Suzhou) Co., Ltd. angel funding from Weidu Capital.

The company self-developed in-vivo flow cytometer (IVFC) which enables blood-free, real-time, dynamic, continuous, non-invasive, quantitative detection/monitoring of target substances such as cells, molecules, and nanoparticles in the circulatory system of humans or animals, and reflects the real molecular, physiological, metabolic, and drug parameters and states of the human or experimental animal's internal environment. The technology is widely used for unlabeled pan-tumor species CTC (Circulating Tumor Cell), immune cells, stem cells, platelets, drug molecules, lipid molecules, nanoparticles, and therapeutic light capture CTC, light therapy for Parkinson's disease.

The company plans to its proceeds from August 2022 funding for the research and development and clinical technology innovation for bulk flow cytometry products.

## Funding rounds

- Angel, Aug 18, 2022 — Weidu Capital

## Investors

- Weidu Capital (https://capitalatlas.ai/funds/weidu-capital) — Angel